Bausch Health Companies (BHC) EPS (Weighted Average and Diluted) (2009 - 2026)

Bausch Health Companies has disclosed EPS (Weighted Average and Diluted) across 18 years of filings, most recently posting -$3.82 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$3.82, down 2287.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.24 (down 2845.45% YoY), and the FY2025 annual result was $0.42, up 423.08% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$3.82 for Q1 2026 at Bausch Health Companies, down from -$0.3 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.1 in Q3 2022 to a low of -$3.82 in Q1 2026.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.17 (2024), against an average of -$0.34.
• Across the five-year window, EPS (Weighted Average and Diluted) soared 1233.33% in 2025 and slumped 2287.5% in 2026, its largest moves.
• Bausch Health Companies' EPS (Weighted Average and Diluted) stood at -$1.13 in 2022, then surged by 91.15% to -$0.1 in 2023, then soared by 350.0% to $0.25 in 2024, then slumped by 220.0% to -$0.3 in 2025, then tumbled by 1173.33% to -$3.82 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$3.82 (Q1 2026), -$0.3 (Q4 2025), and $0.48 (Q3 2025), per Business Quant data.